Back to Search Start Over

Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study.

Authors :
Liu ZY
Tan XY
Li QJ
Liao GC
Fang AP
Zhang DM
Chen PY
Wang XY
Luo Y
Long JA
Zhong RH
Zhu HL
Source :
Nutrition & metabolism [Nutr Metab (Lond)] 2018 Nov 20; Vol. 15, pp. 81. Date of Electronic Publication: 2018 Nov 20 (Print Publication: 2018).
Publication Year :
2018

Abstract

Background: Evidence has suggested a potential link exists between trimethylamine-N-oxide (TMAO), a choline-derived metabolite produced by gut microbiota, and some cancers, but little is known for primary liver cancer (PLC).<br />Methods: A case-control study was designed including 671 newly diagnosed PLC patients and 671 control subjects frequency-matched by age (±5 years) and sex, in Guangdong province, China. High-performance liquid chromatography with online electrospray ionization tandem mass spectrometry (HPLC-MS/MS) was used to measure serum TMAO and choline. The associations between these biomarkers and PLC risk were evaluated using logistic regression models.<br />Results: Serum TMAO concentrations were greater in the PLC group than the control group ( P  = 0.002). Logistic regression analysis showed that the sex- and age-adjusted odds ratio (OR) and (95% confidence interval [CI]) was 3.43 (2.42-4.86) when comparing the top and bottom quartiles (Q4 vs Q1). After further adjusting for more selected confounders, the OR (95% CI) remained significant but was attenuated to 2.85 (1.59-5.11) (Q4 vs Q1). The multivariable-adjusted ORs (95% CIs) across quartiles of choline were 0.35-0.15 ( P <subscript>-trend</subscript>  < 0.001).<br />Conclusion: Higher serum levels of TMAO were associated with increased PLC risk. The association was stronger in those with lower serum levels of choline. Additional large prospective studies are required to confirm these findings.<br />Trial Registration: This study was registered at clinicaltrials.gov as NCT 03297255.<br />Competing Interests: Written informed consent was provided by all study participants, and the study protocol was approved by the Ethics Committee of the School of Public Health at Sun Yat-sen University.Not applicable.The authors declare that they have no competing interests.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Details

Language :
English
ISSN :
1743-7075
Volume :
15
Database :
MEDLINE
Journal :
Nutrition & metabolism
Publication Type :
Academic Journal
Accession number :
30479648
Full Text :
https://doi.org/10.1186/s12986-018-0319-2